The inorganic NItrate and eXercise performance in Heart Failure (iNIX-HF) phase II clinical trial: Rationale and study design

Authors

Andrew R Coggan, Indiana University
Lauren K Park, Washington University School of Medicine in St. Louis
Susan B Racette, Arizona State University
Victor G Davila-Roman, Washington University School of Medicine in St. Louis
Pattie Lenzen, Washington University School of Medicine in St. Louis
Kathryn Vehe, Barnes-Jewish Hospital
Peter M Dore, Washington University School of Medicine in St. Louis
Kenneth B Schechtman, Washington University School of Medicine in St. Louis
Linda R Peterson, Washington University School of Medicine in St. Louis

Journal

Contemporary Clinical Trials Communications

Publication Date

12-1-2023

Volume

36

First Page

101208

Document Type

Open Access Publication

DOI

10.1016/j.conctc.2023.101208

Rights and Permissions

Coggan AR, Park LK, Racette SB, Davila-Roman VG, Lenzen P, Vehe K, Dore PM, Schechtman KB, Peterson LR. The inorganic NItrate and eXercise performance in Heart Failure (iNIX-HF) phase II clinical trial: Rationale and study design. Contemp Clin Trials Commun. 2023 Oct 2;36:101208. doi: 10.1016/j.conctc.2023.101208. © 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Recommended Citation

Coggan, Andrew R; Park, Lauren K; Racette, Susan B; Davila-Roman, Victor G; Lenzen, Pattie; Vehe, Kathryn; Dore, Peter M; Schechtman, Kenneth B; and Peterson, Linda R, "The inorganic NItrate and eXercise performance in Heart Failure (iNIX-HF) phase II clinical trial: Rationale and study design." Contemporary Clinical Trials Communications. 36, 101208 (2023).
https://digitalcommons.wustl.edu/oa_4/2604

Department

ICTS (Institute of Clinical and Translational Sciences)